A deadline is coming up on January 21, 2017 in the settlement reached in the securities class action lawsuit filed for investors who purchased NASDAQ: DVAX shares between April 26, 2012 and June 10, 2013.
Investors who purchased a significant amount of shares of Dynavax Technologies Corporation (NASDAQ: DVAX) between April 26, 2012 and June 10, 2013, have certain options and should contact the Shareholders Foundation by email at email@example.com or call +1(858) 779 – 1554.
The settlement proof of claim form or detailed settlement notice for the settlement in the Dynavax Technologies Corporation (NASDAQ: DVAX) Investor Securities Class Action Lawsuit can be downloaded at: http://shareholdersfoundation.com/case/dynavax-technologies-corporation-nasdaq-dvax-investor-securities-class-action-lawsuit-06182013
In order to submit a claim an investor has to submit the claim proof to the class action claim administrator in a timely manner. The deadline to submit the proof with the class administrator is January 21, 2017. The class action administrator for this case is Garden City Group.
The lawsuit was originally filed in the U.S. District Court for the Northern District of California against Dynavax Technologies Corporation over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements made between April 26, 2012 and June 10, 2013. According to the complaint the plaintiff alleges on behalf of purchasers Dynavax Technologies Corporation (NASDAQ: DVAX) common stock during the period between April 26, 2012 and June 10, 2013, that Dynavax Technologies Corporation and certain of its officers and directors violated the Securities Exchange Act of 1934 by disseminating allegedly false and misleading statements to the investing public about the viability of HEPLISAV, an investigational adult hepatitis B vaccine.
Those who purchased NASDAQ: DVAX shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego